C D47 is an Ig superfamily transmembrane protein that is universally expressed on mammalian cells and tissues. Through its trans interactions with SIRPa on macrophages, CD47 triggers tyrosine phosphorylation in the SIRPa cytoplasmic ITIMs and recruitment of protein tyrosine phosphatases SHP-1/SHP-2, which further mediate negative signaling events that inhibit macrophage phagocytosis. For this, CD47 acts as a self marker and prevents macrophage engulfment of host cells (1, 2) . This self-recognition system mediated by CD47-SIRPa interaction plays a critical role in restraining macrophages. On one hand, disruption of CD47-SIRPa interaction would lead to normal tissue damage (3) (4) (5) (6) , whereas, on the other hand, preservation of this self-recognition could result in a failure to clear apoptotic cells, pathogen-infected cells, or tumor cells (7) .
Recent studies of cell apoptosis and how apoptotic cells are cleared by macrophages suggest that three kinds of potential signals control macrophages to target apoptosis cells. The first signal is a "find me" signal. The apoptotic cells release soluble factors, such as lysophosphatidylcholine (8) , which act as chemoattractants to recruit macrophages or other phagocytes. Following the approach of macrophages, molecules that are especially increased on apoptotic cells, such as phosphatidylserine (PS) (9) and calreticulin (10, 11) , initiate "eat me" signaling, the second class of signal (7, 8) . Meanwhile, CD47, through ligation of macrophage SIRPa, provides an additional control, the "don't eat me" signal, which should restrain the process initiated by the first two classes of signaling. Because apoptotic cells do get engulfed by host macrophages, some explanation regarding the inability of this usually effective final veto is required. Evidence suggests that apoptotic cells, as well as senescent cells, may lose their surface CD47 or change its cell surface-localization pattern (12) (13) (14) , resulting in a dysfunctional "don't eat me" signal. However, the mechanism that governs the changes in both the cell surface expression level and the pattern of CD47, as well as how the CD47 pattern change affects CD47-SIRPa interaction during apoptosis, is incompletely understood.
In the current study, we monitored the kinetics of the cell surface level and pattern of CD47, as well as CD47-SIRPa interaction, following UV radiation-induced cell apoptosis or apoptosis induced by other means. Our results showed that cell apoptosis does not decrease the level of CD47 on the cell surface, but it alters the cell surface pattern of CD47 from punctate clusters into a diffused distribution, which dramatically decreases the avidity of CD47-mediated cell binding to SIRPa and disables SIRPa-mediated inhibitory signaling in macrophages. Our data further suggest that dispersion of surface CD47 is related to apoptosis-induced disruption of lipid rafts in the plasma membrane.
Materials and Methods

Cells, Abs, and reagents
Human colonic epithelial cells (HT-29), human mammary gland epithelial cells (T47D, MCF7, MDA435, and HS578T), and primary cultured human foreskin fibroblasts (HFF-1; all from American Type Culture Collection) were maintained in DMEM supplemented with 10% FBS. Human microvascular endothelial cells (HMEC-1), which were initially established by Dr. E.W. Ades (Centers for Disease Control and Prevention, Atlanta, GA) (15) , were maintained in MCDB 131 medium with 10 mM/l L-glutamine, 10 ng/ml mouse epidermal growth factor (BD Biosciences), 1 mg/ml hydrocortisone (Sigma), and 10% FBS and were used within 15 passages (16) . Human acute monocytic leukemia cells (THP-1; American Type Culture Collection) were cultured in RPMI 1640 supplemented with 50 mM 2-ME and 10% FBS (16) . Human peripheral polymorphonuclear leukocytes (PMNs) were isolated from whole blood of healthy volunteers (16) (17) (18) . Murine splenocytes were isolated from spleens of healthy C57BL/6 mice. Mouse mAbs against the human CD47 extracellular domain (B6H12.2 and PF3.1) and the human SIRPa extracellular domain (SIRPa.ex; SE5A5 and SE7C2), as well as a rabbit polyclonal Ab against SIRPa.ex (anti-SIRPa.ex), were used previously (17) (18) (19) . The IgG Fab fragment of PF3.1 was prepared by cleavage with papain protease using a Fab Preparation Kit (Thermo Scientific, Rockford, IL). Mouse mAb clone 4G10 (EMD Millipore) was used to detect protein tyrosine phosphorylation; anti-SHP-1 Ab was purchased from Santa Cruz Biotechnology. Rat mAb against mouse CD47 (miap301) was purchased from BD Biosciences. The anti-actin Ab and FITC-conjugated cholera toxin B subunit (CT-B) were obtained from Sigma. A recombinant fusion protein containing SIRPa.ex and rabbit Fc (SIRPa.ex-Fc) was generated and used previously (20, 21) . Another recombinant fusion protein containing the entire extracellular domain of human CD47 and alkaline phosphatase (CD47-AP), which functionally ligates SIRPa, was generated in the laboratory (17, 21, 22) . Octylglucoside (OG) was from Millipore. Other essential reagents, including methyl-b-cyclodextrin (MbCD), LPS, lectin from Psophocarpus tetragonolobus, PMA, protease inhibitors, and cocktails, were purchased from Sigma.
Cell apoptosis
Apoptosis of HT-29, T47D, HS578T, MCF7, HFF-1, and HMEC-1 cells was induced by UV radiation in 35-mm Petri dishes in the absence of cell culture medium. Specifically, after removal of culture medium, the dishes were placed under a UV/cross-linker (model XL-1000; Spectronics) and irradiated for various time periods, all within 200 s, to achieve induction of cell apoptosis that starts at 2-4 h post-UV radiation, but not necrosis or instant death (the total energy strength for different cell types is listed in Table I) . After UV radiation, the culture medium was added back to the dishes, and the cells were cultured for various time periods until analysis. Cell apoptosis was assessed by labeling with FITC-conjugated Annexin V (Sigma) for cell surface PS and YO-PRO-1 iodide (Life Technologies) for cell nuclei. Cell necrosis or dead cells were detected by staining with propidium iodide (PI). Cell apoptosis also was assessed by Western blot (WB) to detect cleavage of poly (ADP-ribose) polymerase (PARP) using a rabbit polyclonal anti-PARP Ab (Roche).
Cell adhesion assay
Cell adhesion to immobilized recombinant proteins was performed according to previously described methods (21, 23) , with modifications. Briefly, purified SIRPa.ex-Fc (10 mg/ml), lectin (50 mg/ml), control BSA (5%), or anti-CD47 mAb PF3.1 (10 mg/ml) in HBSS were immobilized in 96-well microtiter plates by incubation for 2 h at 25˚C or overnight at 4˚C. After blocking with HBSS containing 2% BSA and 5% normal goat serum (1 h, 25˚C), the wells were incubated with suspensions of cells (1-5 3 10 5 ) for 30 min (25˚C) in the presence or absence of inhibitory Abs or peptides. After incubation, the wells were washed gently three times using a 27-gauge needle connected to a vacuum, followed by microscopic analysis of cell adhesion. In some experiments, cells were labeled with a fluorescent dye, 29,79-bis(carboxyethyl)-5,6-carboxyfluorescein, prior to incubation with immobilized proteins. Cell adhesion was quantified using a fluorescence plate reader (Perkin Elmer) by reading the fluorescence intensity of the total load versus the after wash.
Surface plasmon resonance measurement
The binding avidity of cells to immobilized SIRPa was analyzed using surface plasmon resonance (SPR) technology. Briefly, a new CM5 chip (Biacore; GE Bioscience) with four binding surfaces/channels was placed into the Biacore T100 system (GE Healthcare), followed by binding surface activation using 400 mM 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide and 100 mM N-hydroxysuccinimide, according to the standard protocol in the Biacore Sensor Surface Handbook (GE Healthcare). After activation, one channel was used as the reference, and three were used for binding experiments. To immobilize SIRPa.ex-Fc on the chip, purified SIRPa.ex-Fc (100 mg/ml) in NaAc/HAc buffer (pH 5) was injected into activated channels. The final response unit change with immobilized protein was ∼4500. After protein coating, 1 M ethanolamine was injected into the channels to neutralize residual activated carboxyl groups. The reference channel was blocked directly with ethanolamine. For cell adhesion experiments, cells suspended in HBSS (1 3 10 7 cells/ml) were injected into the channels at a flow rate of 3 ml/min, which was lasted $500 s. Continual flow of HBSS at the same rate was provided after the cell injection. To terminate cell binding, the channels were washed/regenerated by running 5 M LiCl in HEPES (pH 7.3) for 15 min at a flow rate of 3 ml/min.
In vitro binding assay of purified CD47 to SIRPa CD47 purification from various cells was described previously (17) . Briefly, nonapoptotic cells and cells that were 6 h post-UV radiation (.5 3 10 8 each) were lysed in cold buffer (50 mM Tris-HCl [pH 7.5], 150 mM NaCl, 2 mM MgCl 2 , 1% Nonidet P-40, 1% Triton X-100, 0.5% sodium deoxycholate, protease inhibitor mixture [Sigma] , and 1 mM PMSF). After preclearing using a control IgG-conjugated Sepharose, the lysates were incubated with Sepharose conjugated with PF3.1 (2 mg IgG/ml). After incubation, the beads were washed with the detergent changed to 1% OG. After washing, CD47 was eluted in a buffer containing 50 mM TEA (pH 10.5), 1% OG, and 100 mM NaCl, followed by neutralization. To assay CD47 binding to SIRPa.ex-Fc, purified CD47 (∼100 mg/ml in buffer containing 1% OG) was diluted 10-fold in HBSS in ELISA wells, and protein coating was allowed for 2 h (25˚C). Then the wells were blocked and incubated with SIRPa.ex-Fc (5 mg/ml) in HBSS for 30 min in the presence or absence of anti-CD47 or anti-SIRPa mAb (5 mg/ml). After washing, SIRPa.ex binding was detected using a peroxidase-conjugated goat anti-rabbit Fc Ab and the substrate 2,29-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid).
Immunofluorescence labeling, FACS, and microscopy
Trypsinized cells were blocked with 5% normal goat serum, followed by cell surface labeling of CD47 with Ab B6H12.2 or PF3.1 (30 min). Cells labeled with mouse normal IgG were used as controls. To label cells growing in the culture dishes, cells were treated briefly with 1 mM EDTA to disassemble the intercellular junctions (20) before blocking and CD47 labeling. After primary Ab labeling, cells were washed and labeled with Alexa Fluor-conjugated anti-mouse secondary Ab (Invitrogen), followed by FACS, fluorescence microscopy, or confocal microscopy in the presence of anti-fade reagent (Molecular Probes). CD47 granularities and particle fluorescence intensities were analyzed by National Institutes of Health (NIH) ImageJ software and Nikon NIS-Elements B.R. 4.20.00 software. In some experiments, CD47-expressing cells were incubated with SIRPa.ex-Fc (5 mg/ml) in HBSS (30 min, 4˚C). After washing, SIRPa.ex-Fc binding was detected with an Alexa Fluor-conjugated antirabbit Fc Ab. Plasma membrane lipid rafts were labeled with FITCconjugated CT-B (30 min, 4˚C).
Immunoprecipitation and WB analysis
Cells were lysed with an ice-cold lysis buffer containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1% Nonidet P-40, 1% Triton X-100, 0.5% sodium deoxycholate, a mixture of protease inhibitors (Sigma), and 1 mM PMSF. Clear cell lysates were obtained by centrifugation at 14,000 rpm (10 min). For WB of CD47, cell lysates were supplemented with NaIO 4 (10 mM, to enhance CD47 detection) prior to mixing with nonreducing SDS-PAGE sample buffer and heating (5 min, 60˚C). After transferring proteins onto nitrocellulose, the membrane was blocked with 5% nonfat milk, followed by detection using anti-CD47 mAb B6H12.2 (2 mg/ml, 1 h, 25˚C). For WB of actin and PARP, SDS-PAGE was performed under reducing conditions. For WB of SIRPa, anti-SIRPa.ex was used. For immunoprecipitation of SIRPa, THP-1 macrophage lysates were incubated with 1-2 mg anti-SIRPa. ex and protein A-conjugated Sepharose for 4 h (4˚C). After washing, the beads were heated in 13 SDS-PAGE sample buffer to release proteins, and samples of prebound lysates, postbound lysates, and immunoprecipitates were separated by SDS-PAGE, followed by WB for SIRPa. To detect SIRPa phosphorylation, THP-1 macrophages were treated with freshly prepared pervanadate (2 mM, 3 min, 37˚C) prior to cell lysis and immunoprecipitation. The tyrosine phosphorylated SIRPa after immunoprecipitation was detected using mAb 4G10, and SIRPa-associated SHP-1 was detected using an anti-SHP-1 Ab.
Phagocytosis assay and cytokine detection
Cultured THP-1 cells were induced to differentiate into phagocytic macrophages using PMA (100 nM) for 3 d (37˚C). After induction, THP-1 cells changed morphology and adhered to the culture dish. To assay THP-1 macrophage phagocytosis, healthy cultured cells (control) and cells that were induced to undergo apoptosis were loaded with CFSE or labeled with YO-PRO-1 iodide (for apoptotic cells) prior to incubation with THP-1 phagocytes at 37˚C. After 30 min, the dishes were washed gently to remove floating cells, and THP-1 phagocytes were stained with a PEconjugated anti-CD11b Ab, followed by fluorescence microscopy. To determine phagocytosis, macrophages (CD11b + , red) in five or six views with a total cell number . 200 were analyzed for ingestion of target cells that were stained with CFSE (green) or YO-PRO-1 (apoptotic marker, green). Successful phagocytosis was exhibited by macrophages in which green cells were ingested or partially ingested (showing green staining), whereas macrophages without green staining were not considered phagocytic. Alternatively, a fluorescence plate reader (Perkin Elmer) was used to assess phagocytosis, and in those experiments, only target cells were labeled green. This method is normally used in combination with microscopic determination. To detect cytokines produced during phagocytosis, THP-1 macrophages (2 3 10 5 ) were incubated with healthy cells or cells that were treated by UV radiation or other methods (1 3 10 5 each cell sample). At various time points (2, 4, 6, 8 , and 18 h), the cell-free media from the THP-1-target cell coincubation were collected for ELISA detection of IL-10, IL-6, and TNF-a using capture and detection Abs (24, 25) .
Lipid raft staining and disruption
HT-29 cells were stained with FITC-conjugated CT-B to identify lipid rafts (26) . To disrupt lipid rafts on cell surfaces, cells were incubated with 15 mM MbCD for 20 min at 37˚C (27) .
Statistical analysis
All figures showing immunofluorescence labeling, FACS, and WBs represent the results of at least three independent experiments. Data are presented as the mean 6 SD or SEM for three or more independent experiments. Differences were considered statistically significant at p , 0.05, as analyzed using the Student t tests for paired samples and one-way ANOVA for k . 2 samples.
Results
Cell apoptosis does not reduce the cell surface level of CD47 expression
It is generally believed that the interaction between the phagocyte surface SIRPa and the self-recognition marker protein CD47 controls the phagocytosis of self-cells by phagocytes, such as macrophages, and that during cell aging or apoptosis, cells may lose surface CD47 and/or the interaction with SIRPa to be phagocytized (5, 6) . To test whether cells lose their surface CD47 when apoptosis occurs, we examined the expression level of CD47 on multiple types of cells prior to and after the induction of apoptosis. For these experiments, human colonic epithelial cells (HT-29), breast cancer cells (T47D and MCF7), and other types of cells were exposed to UV radiation (energy levels used for different cells are listed in Table I ) or other ways to induce apoptosis. As shown in Fig. 1A , HT-29, MCF7, and T47D cells started to display apoptosis at ∼4 h post-UV radiation, as indicated by the cell surface labeling of PS by FITC-conjugated Annexin V, which started to show positive staining at 4 h and grew stronger thereafter. Cell apoptosis also was confirmed by the cleavage of PARP, a DNA-repairing polymerase that is cleaved under apoptosis (28) (Fig. 1B) . Because cell necrosis (secondary necrosis) generally occurs following apoptosis (29) (30) (31) , costaining with YO-PRO-1 iodide (green) and PI (red) was applied to differentiate cells that were apoptotic (YO-PRO-1 + PI 2 ) and necrotic (PI + YO-PRO-1 + ). As shown in Table I , cells began apoptosis 2 h after UV radiation; at 8 h, all cells were YO-PRO-1 + . Cell necrosis started to show at 6 h post-UV radiation and gradually increased over time. At 18 h post-UV radiation, all cells were necrotic and PI + . Therefore, in our analyses of apoptotic cells, cells within 8 h post-UV radiation were generally used, and YO-PRO-1/PI staining, to distinguish apoptosis from necrosis, was included in the experiments.
As shown in Fig. 1A -C, despite the fact that cells had undergone apoptosis, cell surface labeling with mAbs against the CD47 extracellular domain (B6H12.2 and PF3.1) showed that CD47 was continuously expressed on the cell surface without significant reduction until later time points when cells became necrotic (18 h post-UV radiation, Fig. 1C ). Detailed flow cytometric analyses (Fig. 1D) Furthermore, we observed that membrane blebs emerged around the cell bodies when cells started apoptosis and then necrosis. This phenomenon, which was reported previously, likely reflects vigorous dynamics and/or destabilization of the plasma membrane during apoptosis, resulting in partial plasma membrane dissociation from the underlying cytoskeleton cortex (32) (33) (34) (35) . For cell apoptosis, especially during the early stages (4-6 h post-UV radiation), the membrane blebs were small relative to the cell body, transient, and deficient in CD47 (Fig. 1E, white arrows) . However, when apoptosis progressed to necrosis, large membrane blebs formed (relative to the remnant cell body) on which CD47 staining was positive (Fig. 1E, white arrows) . Shedding of these large membrane blebs may explain the loss of both CD47 molecules and cell size in necrotic cells.
Similar results were obtained when studying apoptosis of other cell types, such as human fibroblasts (HFF-1) and human microvascular endothelial cells (HMEC-1) (both nontransformed cells), breast cancer cells (MDA435, MDA468, MDA231, and HS578T), murine cell lines B16 and MC38, freshly isolated murine splenocytes (.90% lymphocytes), and freshly isolated human neutrophils (PMNs). As shown in Fig. 2A and 2B and Table I , UV radiation induced apoptosis of HFF-1 cells, HMEC-1 cells, and various breast cancer cells, as indicated by positive YO-PRO-1 labeling and the cleavage of PARP, without noticeably affecting CD47 expression on the cell surface, as determined by anti-CD47 labeling, as well as immunoblot analysis. Apoptosis in murine splenocytes was induced by treatment with H 2 O 2 (5 mM), and this was not associated with the cell surface reduction in CD47, as assessed by a murine CD47 extracellular domain-specific Ab (mAb miap301) (Fig. 2C) . Similar results of no CD47 reduction were observed in B16 and MC38 cells when apoptosis was induced by UV radiation (data not shown). Unlike other cells, and in agreement with a previous report, freshly isolated human PMNs without stimulation express only low levels of CD47 on the cell surface, and store the majority of CD47 in intracellular-specific granules (18) ; chemoattractant stimulation induces PMN degranulation and, hence, mobilizes CD47 to the cell surface (18) . In this study, we treated PMNs with the chemoattractant fMLF for 15 min to increase cell surface CD47 (Fig. 2D) prior to inducing apoptosis by incubating them on ice in the presence of 20 mM
The Journal of ImmunologyEDTA (EDTA also prevents PMN aggregation). As shown in Fig. 2D , PMNs that were incubated on ice overnight (.14 h) were apoptotic and displayed positive YO-PRO-1 staining; however, this treatment of PMN also did not result in reduction of CD47 on the cell surface. In conclusion, our results indicate that cell apoptosis, per se, does not lead to loss of CD47 on the cell surface. However, when apoptosis proceeds to secondary necrosis the cell sizes are reduced, and CD47 proteins remaining on the remnant cell surfaces are coordinately decreased.
Macrophage phagocytosis of apoptotic cells regardless of CD47 expression
Given that CD47 serves as a self marker, and its interactions with SIRPa on phagocytes inhibit macrophage phagocytosis, we asked whether apoptotic cells with CD47 expression could be phagocytized by macrophages. For these experiments, HT-29 cells were loaded with a fluorescent tracer (CFSE) prior to the induction of apoptosis by UV radiation. At various time points post-UV radiation, HT29 cells were incubated with THP-1-differentiated macrophages to allow phagocytosis. As shown in Fig. 3A and 3B, THP-1 macrophages (labeled with anti-CD11b Ab, red) displayed aggressive phagocytosis toward HT-29 cells 4 h post-UV radiation, despite the fact that ample CD47 remained on the target cells. Apoptotic cells (4-8 h post-UV radiation) were rapidly grabbed and engulfed by macrophages and, thus, formed a wide area of orange labeling in merged images. THP-1 macrophages also aggressively ingested necrotic cells but completely avoided nonapoptotic cells. We assayed cytokines produced by THP-1 macrophages during phagocytosis. As shown in Fig. 3C , cell-free supernatants collected from the THP-1 macrophage-HT29 incubation (37˚C, 3 h) confirmed that phagocytosis of CD47-expressing apoptotic HT29 cells (4-8 h post-UV radiation) was associated with induction of the anti-inflammatory cytokine IL-10 but suppression of IL-6 and TNF-a. Conversely, phagocytosis of necrotic cells that were 18 h post-UV radiation was associated with significant induction of proinflammatory IL-6 and TNF-a. Similar results were obtained when testing THP-1 phagocytosis of apoptotic and necrotic HFF-1 cells, HMEC-1 cells, and various breast cancer cells (data not shown). Together, these results suggest that, although CD47 expression remains on apoptotic cells, it does not prevent macrophage clearance. Phagocytosis of CD47-expressing apoptotic cells is a physiologically relevant, immunosuppressive event, whereas phagocytosis of necrotic cells is associated with proinflammatory conditions. Although CD47 molecules were on the surface of apoptotic cells, they were incapable of inducing SIRPa-mediated inhibitory signaling in macrophages. Addition of a SIRPa-binding CD47 extracellular domain (CD47-AP) and a SIRPa-ligating mAb (SE7C2), both capable of triggering SIRPa-mediated inhibitory signaling, inhibited macrophage phagocytosis of apoptotic cells (Fig. 3B) . As shown in Fig. 3D , direct incubation of apoptotic cells with THP-1 macrophages failed to trigger SIRPa ITIM tyrosine phosphorylation (SIRPa pY ) and/or recruitment of SHP-1. The same manner of coincubating healthy, nonapoptotic cells with macrophages resulted in SIRPa phosphorylation and SIRPa association with SHP-1. Consistent with their inhibition in phagocytosis, addition of CD47-AP and SE7C2 into the THP-1 and apoptotic cell coincubation led to SIRPa phosphorylation and SHP-1 association.
CD47 on apoptotic cell surface has low binding avidity to SIRPa
Since CD47 molecules on the apoptotic cells do not prevent macrophage phagocytosis, we speculate that CD47 on apoptotic cells might not interact with SIRPa on macrophages. To test this possibility, we first evaluated whether CD47 molecules in apoptotic cells were intact and could bind to SIRPa. CD47 was affinity-purified from various, nonapoptotic and apoptotic cells, and then tested for binding to SIRPa using a recombinant SIRPa extracellular domain fusion protein (SIRPa.ex-Fc). As shown in Fig. 4 , CD47 proteins purified from normal cultured, nonapoptotic cells and UV-induced apoptotic cells displayed equal binding to SIRPa.ex-Fc. The binding interactions between CD47 and SIRPa were confirmed by including the extracellular domain-specific inhibitory mAbs for CD47 (B6H12.2) and SIRPa (SE5A5), both abrogating the binding. Although the above assays using purified CD47 suggested that the binding capacity of CD47 to SIRPa was not affected by apoptosis, the cell adhesion assays suggested otherwise. As shown in Fig. 5A -C, stationary incubation of immobilized SIRPa (SIRPa.ex-Fc-coated wells) with healthy cultured, nonapoptotic cells resulted in effective, CD47-SIRPa interaction-mediated cell adhesion. In support of this, B6H12.2 and SE5A5 were applied and these mAbs completely blocked healthy cells from adhering to immobilized SIRPa.ex-Fc. However, the same manner of SIRPa.ex-Fccoated wells incubating with apoptotic cells completely failed to produce cell adhesion (Fig. 5A-C) . However, apoptosis did not diminish cell adhesion mediated by lectin or anti-CD47 Ab (Fig. 5D) . We further analyzed the differences between apoptotic cells and nonapoptotic cells, with regard to adhesion to immobilized SIRPa, using SPR. For these experiments, healthy cultured cells and apoptotic cells of the same type were set to flow through CM5 chip surfaces coated with SIRPa.ex-Fc. As shown in Fig. 5E , nonapoptotic cells exhibited rapid attachment/retention to the chip and demonstrated effective CD47-mediated adhesion to SIRPa. In contrast, apoptotic cells displayed no evident retention/attachment to the SIRPa.ex-coated chip under flow. These results show that apoptotic cells lost the ability to mediate strong (high-avidity) cell surface binding to immobilized SIRPa via CD47 and were washed away by the flow shear force.
Multiple other types of cells were tested in cell adhesion assays, and all yielded similar results, indicating that apoptosis led to loss (Table I ). For cells in R1, an increase in YO-PRO-1 staining was seen 4 h after UV radiation, whereas the cell surface CD47 did not change significantly. The surface level of CD47 for cells in R1 was consistently higher than for cells in R2. (E) Plasma membrane blebs and CD47 distribution. Note that the blebs (white arrows) that emerged at the stage of apoptosis (4-8 h post-UV radiation) were generally depleted of CD47, whereas the blebs formed during necrosis (18 h post-UV radiation) were CD47 + .
The Journal of Immunologyof high-avidity CD47-mediated cell binding to SIRPa (Fig. 5F ). However, incubation of SIRPa.ex-Fc in solution with apoptotic cells resulted in SIRPa-CD47 binding (Fig. 5G ). This result again indicates that failure of apoptotic cells to firmly adhere to immobilized SIRPa is not due to depletion of CD47 on apoptotic cells or a change in CD47 extracellular domain structure; rather, it is related to the protein-binding avidity.
Distribution change of CD47 from cluster to diffuse pattern on cell surface during apoptosis
Our previous study found that SIRPa forms clusters on the macrophage surface, and such a formation of SIRPa plays a key role in mediating high-avidity cell interaction with CD47 (16) . In this study, we asked whether CD47 also clusters on the cell surface. We compared the cell surface distribution patterns of CD47 on nonapoptotic cells and apoptotic cells. To avoid possible Ab cross-linking, we used Fab fragments of both anti-CD47 and fluorophore-conjugated secondary Abs to label cell surface CD47. As shown in Fig. 6A , immunofluorescence microscopy revealed that CD47 on nonapoptotic HT29 cells was distributed in an uneven, punctate pattern, suggestive of cluster formation (Fig. 6A,  left panel, arrowheads) . In contrast, CD47 on apoptotic cell surfaces was diffuse, resulting in relatively weak visual effects when the stained images were analyzed microscopically (Fig. 6A, right  panel) , despite the fact that the actual level of CD47 had not changed significantly. Analyses of multiple other types of cells found the same changes in CD47 distribution after apoptosis (Fig. 6B) . The use of NIH ImageJ and Nikon software (NISElements B.R. 4.20 .00) to analyze cell surface CD47 distribution and CD47 clusters/granules revealed remarkable differences between normal nonapoptotic cells and apoptotic cells. As shown in Fig. 6C , ImageJ analysis showed that both the number and the sizes of CD47 granules/clusters on the cell surfaces were decreased significantly after apoptosis. In particular, CD47 granules/ clusters . 50 pixel 2 were distributed on nonapoptotic cells but were deficient on apoptotic cells. In contrast, on apoptotic cells, CD47 was distributed primarily as small particles , 20 pixel 2 . Fig. 6D shows that, on nonapoptotic cells, cluster-forming CD47 emitted high-intensity scattered peaks of fluorescence, whereas on apoptotic cells diffuse CD47 emitted broad, but weak, fluorescence. As depicted in Fig. 6E , this marked change in CD47 distribution after apoptosis correlates with the alteration in CD47-binding avidity to SIRPa in adhesion assays, suggesting that, although individual CD47 is capable of binding, the overall low binding avidity of CD47 on apoptotic cells is insufficient to hold the cell in place. Our previous studies demonstrated that SIRPa clusters on macrophages; thus, it is essential that CD47 also forms clusters to mediate high-avidity cell surface interaction and strong inhibitory signal transduction, effectively suppressing macrophage phagocytosis. Apoptosis-associated dispersal of CD47 significantly reduces the avidity of SIRPa ligation and, hence, facilitates macrophage phagocytosis.
Disrupting lipid rafts results in dispersion of surface CD47 clusters and a reduction in CD47-binding avidity to SIRPa
It is widely reported that clustering of cell membrane receptors requires them to be located in lipid rafts in the plasma membrane; such lipid raft-supported receptor clustering plays an essential role in maintaining the structure and function of receptors (36) (37) (38) . We performed several experiments to test whether the clustering of CD47 on healthy cell surfaces is associated with lipid rafts. First, we double stained cell surface CD47 and lipid rafts using anti-CD47 Fab and FITC-conjugated CT-B, respectively. Confocal microscopy images of HT-29 cells taken at different focus layers (Fig. 7A, 7B ) revealed that CD47 is largely colocalized with lipid rafts marked by CT-B in large punctate particles on healthy, nonapoptotic cells. Next, we disrupted lipid rafts with the cholesteroldepletion agent MbCD and examined the cell surface pattern of CD47. Treating healthy HT-29 cells with MbCD (15 mM) led to a diffused staining pattern of FITC-conjugated CT-B, suggestive of lipid raft disruption (Fig. 7A, 7B) . Clustering of CD47 on the cell surface also disappeared following MbCD treatment, and CD47 staining displayed a diffuse pattern. ImageJ and Nikon software revealed that MbCD treatment caused changes in CD47 distribution (Table I) , and their cell surface (A) and total (B) CD47 levels were assessed by FACS and WB and compared with cells that were nonapoptotic. Apoptosis was confirmed by positive YO-PRO-1 labeling (A) and cleavage of PARP (B). The mean fluorescence intensity (MFI) values for CD47 labeling on nonapoptotic cells (red) and apoptotic cells (blue) are also shown in (A). Cells labeled with mouse normal IgG were used as negative control. In (B), the actin loading control for the CD47 blot is shown. The same amount of sample was loaded on the gel for detecting PARP (the white line indicates where parts of the image were joined). (C) No apparent alteration in the level of CD47 on mouse splenocytes following H 2 O 2 -induced cell apoptosis. Freshly isolated mouse splenocytes were treated with H 2 O 2 (5 mM, 37˚C) to induce apoptosis (positive YO-PRO-1 staining). The cell surface CD47 was assessed by labeling with a rat anti-mouse CD47 mAb (miap301), followed by FACS. (D) No reduction in cell surface CD47 on fMLF-stimulated PMNs following cell apoptosis. PMNs were freshly isolated from peripheral blood of human donors and stimulated with fMLF (1 mM) for 15 min (37˚C) to induce degranulation and increase cell surface CD47. Apoptosis, monitored by YO-PRO-1 labeling, was induced by incubating the fMLF-stimulated PMNs on ice overnight (.14 h) in the presence of 20 mM EDTA. similar to those of apoptotic cells, mainly diminishing large CD47 clusters that emitted high intensity of fluorescence (data no shown).
We next performed two additional experiments to confirm that nonapoptotic cells treated with MbCD would lose the high-avidity CD47 binding to SIRPa and would promote macrophage phagocytosis. Cell adhesion assays were performed, and cells with and without MbCD treatment were tested for adhesion to immobilized SIRPa.ex-Fc. As shown in Fig. 7C, HT-29, MCF7 , and T47D cells treated with MbCD completely lost stable adhesion to immobilized SIRPa.ex-Fc, indicating that raft disruption abrogated the high-avidity cell surface CD47 binding. Phagocytosis assays (Fig. 7D) , by incubating MbCD-treated cells with THP-1 macrophages, also showed enhanced phagocytosis of MbCD-treated cells compared with nontreated cells, and the presence of CD47-AP and anti-SIRPa mAb SE7C2 significantly inhibited THP-1 phagocytosis toward MbCD-treated cells.
Discussion
Accumulating evidence showed that ligation of macrophage SIRPa by CD47 expressed on the encountered cells prohibits macrophage phagocytosis, whereas failure of SIRPa engagement by CD47 or a deficiency in SIRPa ITIM-mediated signaling promotes macrophage engulfment of the host cell (1, 3, (39) (40) (41) (42) . Through overexpressing CD47 on the surface, certain types of cancer cells can escape macrophage-mediated immune clearance (43, 44) .
However, contrary to previous thoughts, we demonstrate in the current study that the level of CD47 on the cell surface is not reduced during cell apoptosis; instead, the localization pattern of CD47 on the cell surface is altered significantly. On nonapoptotic cells, CD47 is largely clustered into numerous punctates on the cell surface. After apoptosis, the punctate pattern of CD47 disappears and is replaced by a diffuse distribution of CD47 on the cell surface. The shift in cell surface CD47 from clustering punctates to a diffuse FIGURE 4. Purified CD47 from apoptotic cells displayed an intact ability to bind to SIRPa. CD47 was affinity purified from normal cultured cells including HT-29, T47D, and MCF7 cells, freshly isolated human PMNs (hPMN), and apoptotic cells (Apop.), including UV-radiated HT-29, T47D, and MCF7 cells (6 h post-UV radiation) and apoptotic hPMN (overnight on ice with 20 mM EDTA). The purified CD47 samples were coated on microtiter plates, followed by testing for binding to SIRPa.ex using SIRPa.ex-Fc. Binding to the BSA-coated wells served as control. Anti-SIRPa Ab (SE5A5) and anti-CD47 Ab (B6H12.2) were used to block the specific SIRPa-CD47 binding. Data are mean 6 SD (n = 3). distribution is a critical factor for the loss of CD47's ability to suppress macrophage engulfment through ligating SIRPa. Our cell adhesion data derived under both static and flow conditions showed that, although apoptotic cells maintain the expression of CD47 on the cell surface, these CD47 proteins have a low binding avidity and are incapable of mediating firm cell adhesion to immobilized SIRPa. On the contrary, clustered CD47 molecules on healthy, nonapoptotic cells mediate binding with a high avidity and strongly hold cells to immobilized SIRPa, even under a flow shear force. Consistent with these results, apoptotic cells failed to trigger CD47-SIRPa interaction-induced inhibitory signaling, as indicated by SIRPa cytoplasmic ITIM phosphorylation and association with SHP-1, whereas macrophages coincubated with nonapoptotic cells resulted in SIRPa signaling (Fig. 3D) . Moreover, we show that loss of CD47-binding avidity on apoptotic cells is not due to biochemical modifications or defects of CD47 molecules because purified CD47 from healthy and apoptotic cells displayed the same binding activities toward SIRPa. Because SIRPa also presents as clusters on macrophages (16) , it only makes sense that both of these counterreceptors cluster on the cell surfaces to mediate high-density ligations, effectively driving a strong signal transduction leading to inhibition of macrophage phagocytosis. In addition, a study by Burger et al. (13) showed that CD47 on erythrocytes undergoes a conformational change that alters CD47 binding avidity to TSP-1. Those interesting results, together with ones from the current study, reveal a more complex role for CD47 in cell apoptosis and/or senescence, as well as the determination of phagocytic clearance of apoptotic or senescent cells by phagocytes.
Interestingly, we observed that, although apoptosis does not lead to CD47 loss, the subsequent cell necrosis following apoptosis (secondary necrosis) is associated with a reduction in CD47. However, this necrosis is also associated with a significant reduction in the cell sizes. Decreases in CD47 on necrotic cells could be the result of a reduction in cell sizes and the loss of plasma membrane Indeed, membrane blebs appear instantly when cells start apoptosis, and this result is consistent with observations by other investigators (35, 45) . As shown in our study, the formation of blebs around the cell body appeared at 4 h post-UV radiation, the same time point when other apoptotic signs, such as surface PS and PARP-1 cleavage, became apparent. To us, the appearance of these blebs is another indicator, which is easily visualized, of apoptosis, in addition to PS and PARP. As suggested by Charras et al. (34) , membrane blebs are a result of membrane dynamics during which the plasma membrane transiently dissociates/ruptures from the underlying cytoskeleton cortex as a result of nonuniform intracellular hydrostatic pressure. Formation of membrane blebs is not apoptosis specific. Certain active cellular processes, such as cell migration and cell proliferation, or if the cytoskeleton cortex integrity is compromised (e.g., filamin depletion) are also associated with cell blebbing (46) (47) (48) . We observed that from apoptosis to the subsequent secondary necrosis, plasma membrane blebs are increased in size, suggestive of increased levels of plasma membrane destabilization and dissociation from the cortex. Along with these dramatic cellular changes, CD47 remains in the membrane attached to the main cell body without distribution to blebs at the stage of apoptosis, in a way very similar to the pattern of actin reported by Charras et al. (34) , suggesting that CD47 may connect to the underlying cytoskeleton cortex through its cytoplasmic domain. In contrast, at the stage of necrosis membrane blebs are large, tend to detach from the cell body, and are CD47 + . Therefore, the decrease in CD47 on necrotic cells could be the result of shrinkage of the cell and loss of plasma membrane, although the number of CD47 molecules/membrane area may not decrease. This explains why, even during necrosis, the level of CD47 on the remnant cell body is never diminished completely. In our study, we used YO-PRO-1 and PI to distinguish apoptosis from necrosis. We also compared the cytokines released by macrophages during their phagocytosis of apoptotic or necrotic cells. Our data show that macrophage phagocytosis of CD47-expressing apoptotic cells is accompanied by release of IL-10, whereas phagocytosis of those CD47-reduced necrotic cells is associated with IL-6 and TNF-a production.
Our data further revealed that the functional clustering of CD47 on the cell surface is supported by lipid rafts. Immunofluorescence staining showed that cell surface CD47 is largely colocalized with lipid rafts, and disruption of lipid rafts leads to diffusion of CD47. Clustering of CD47 within lipid rafts is in agreement with the previous finding by McDonald et al. (49) , who showed that CD47 is associated with cholesterol-rich lipid rafts on human ovarian carcinoma cells, and it recruits avb3 integrin and its associated signaling molecules into these microdomains in the plasma membranes. An original study by Green et al. (50) showed that cholesterol directly binds to the multiple membrane-spanning domain of CD47 and is an essential component of the avb3/ CD47/G protein signaling complex.
In conclusion, this study demonstrates that cell apoptosis does not reduce CD47 expression but disperses CD47 from clustering in lipid rafts into the plasma membrane; this change of CD47 results in loss of the high binding avidity of CD47 to SIRPa. For healthy cells in tissues, the clustering of CD47 on the cell surface is a functional form supported by lipid rafts in plasma membranes, and this form of CD47 enables effective ligation to SIRPa and triggers SIRPa-mediated inhibition in macrophages.
